Data Sheet 1_PARP inhibition increases sensitivity to cisplatin in non-small-cell lung carcinoma via the induction of TET-dependent hydroxymethylation.pdf

Introduction<p>Platinum-based chemopotentiation by poly (ADP-ribose) polymerase (PARP) inhibitors (PARPi) has been confirmed in some non-small-cell lung carcinoma (NSCLC) models, but the molecular mechanisms of PARPi synergy with chemotherapeutics remain poorly clarified. This study aimed to e...

وصف كامل

محفوظ في:

التفاصيل البيبلوغرافية
المؤلف الرئيسي:	Nevena Grdović (394542) (author)
مؤلفون آخرون:	Anja Tolić (12356555) (author), Mirna Jovanović (6324551) (author), Jovana Rajić (12356561) (author), Marija Đorđević (12356564) (author), Marijana Stojanović (22489306) (author), Stefan Marković Hadžić (22489309) (author), Tijana Marković (22489312) (author), Ana Sarić (21368240) (author), Svetlana Dinić (394543) (author), Jelena Arambašić Jovanović (12356570) (author), Mirjana Mihailović (394547) (author), Ana Podolski-Renić (289289) (author), Milica Pešić (289295) (author), Melita Vidaković (309714) (author), Aleksandra Uskoković (394545) (author)
منشور في:	2025
الموضوعات:	Cell Biology non-small-cell lung carcinoma cells chemosensitivity PARP inhibitor niraparib 5hmC ten–eleven translocations enzymes
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

كن أول من يترك تعليقا!

Data Sheet 1_PARP inhibition increases sensitivity to cisplatin in non-small-cell lung carcinoma via the induction of TET-dependent hydroxymethylation.pdf

مواد مشابهة